Filing Details
- Accession Number:
- 0001140361-25-019474
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-16 16:06:11
- Reporting Period:
- 2025-05-14
- Filing Date:
- 2025-05-16
- Accepted Time:
- 2025-05-16 16:06:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 887359 | Vericel Corp | VCEL | Biological Products, (No Disgnostic Substances) (2836) | 943096597 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1313403 | Dominick Colangelo | 64 Sidney Street Cambridge MA 02139 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-05-14 | 14,062 | $2.65 | 274,416 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-05-14 | 14,062 | $42.25 | 260,354 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-05-15 | 14,063 | $2.65 | 274,417 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-05-15 | 14,063 | $41.53 | 260,354 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2025-05-14 | 14,062 | $0.00 | 14,062 | $2.65 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2025-05-15 | 14,063 | $0.00 | 14,063 | $2.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,063 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct |
Footnotes
- These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2024.
- 6.25% of these options, representing the right to purchase a total of 90,000 shares, became exercisable immediately on May 22, 2017. An additional 6.25% became exercisable on August 8, 2017 and continued to vest in equal quarterly installments from August 8, 2017, contingent upon continued service to the Company.
- These options, which were awarded on May 22, 2017, would otherwise expire and become forfeitable on May 22, 2027.
Billionaire Hedge Funds
